Atypical antipsychotics in the treatment of bipolar disorder - Pharmacological and clinical effects

Citation
E. Dunayevich et Sl. Mcelroy, Atypical antipsychotics in the treatment of bipolar disorder - Pharmacological and clinical effects, CNS DRUGS, 13(6), 2000, pp. 433-441
Citations number
89
Categorie Soggetti
Pharmacology,"Neurosciences & Behavoir
Journal title
CNS DRUGS
ISSN journal
11727047 → ACNP
Volume
13
Issue
6
Year of publication
2000
Pages
433 - 441
Database
ISI
SICI code
1172-7047(200006)13:6<433:AAITTO>2.0.ZU;2-A
Abstract
Atypical antipsychotics are characterised by a low propensity for causing a cute and tardive extrapyramidal symptoms and an increased efficacy against positive and negative symptoms in schizophrenia. A growing literature sugge sts clozapine and other atypical antipsychotics, including olanzapine, risp eridone, and possibly quetiapine and ziprasidone, are also effective in the treatment of bipolar disorder, particularly the manic phase. Symptoms that are refractory to other drugs may respond to these agents. However, antips ychotic treatment can be associated with serious adverse effects, and cauti on needs to be exercised in the prescription of these agents.